Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, View ORCID ProfileWolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Sean Wasserman, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, Neshaad Schrueder, Wesley Solomon, Petro Rousseau, Nicole Wolter, Waasila Jassat, View ORCID ProfileCheryl Cohen, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
doi: https://doi.org/10.1101/2022.01.13.22269211
Hannah Hussey
1Health Intelligence, Western Cape Government: Health, South Africa
2Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa
Mary-Ann Davies
1Health Intelligence, Western Cape Government: Health, South Africa
3Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa
Alexa Heekes
1Health Intelligence, Western Cape Government: Health, South Africa
2Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, South Africa
Carolyn Williamson
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Ziyaad Valley-Omar
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Diana Hardie
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Stephen Korsman
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Deelan Doolabh
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Wolfgang Preiser
5National Health Laboratory Service, South Africa
7Division of Medical Virology, University of Stellenbosch, South Africa
Tongai Maponga
5National Health Laboratory Service, South Africa
7Division of Medical Virology, University of Stellenbosch, South Africa
Arash Iranzadeh
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
Sean Wasserman
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
8Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, South Africa
Linda Boloko
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Greg Symons
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Peter Raubenheimer
9Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa
Abraham Viljoen
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Arifa Parker
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Neshaad Schrueder
10Department of Medicine, Tygerberg Hospital, Stellenbosch University, South Africa
Wesley Solomon
11National Department of Health, South Africa
Petro Rousseau
11National Department of Health, South Africa
Nicole Wolter
12National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
13School of Pathology, University of the Witwatersrand, Johannesburg, South Africa
Waasila Jassat
12National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
Cheryl Cohen
12National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
14School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Richard Lessells
15KwaZulu-Natal Research, Innovation & Sequencing Platform, University of KwaZulu-Natal, Durban, South Africa
Robert J Wilkinson
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
16The Francis Crick Institute, Midland Road, London, NW1 1AT, UK
17Department of Infectious Diseases, Imperial College London, W12 0NN, UK
Andrew Boulle
1Health Intelligence, Western Cape Government: Health, South Africa
3Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, South Africa
Nei-yuan Hsiao
4Division of Medical Virology, University of Cape Town, Cape Town, Western Cape, South Africa
5National Health Laboratory Service, South Africa
6Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa
Article usage
Posted January 14, 2022.
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Sean Wasserman, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, Neshaad Schrueder, Wesley Solomon, Petro Rousseau, Nicole Wolter, Waasila Jassat, Cheryl Cohen, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
medRxiv 2022.01.13.22269211; doi: https://doi.org/10.1101/2022.01.13.22269211
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections – a survival analysis
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Diana Hardie, Stephen Korsman, Deelan Doolabh, Wolfgang Preiser, Tongai Maponga, Arash Iranzadeh, Sean Wasserman, Linda Boloko, Greg Symons, Peter Raubenheimer, Abraham Viljoen, Arifa Parker, Neshaad Schrueder, Wesley Solomon, Petro Rousseau, Nicole Wolter, Waasila Jassat, Cheryl Cohen, Richard Lessells, Robert J Wilkinson, Andrew Boulle, Nei-yuan Hsiao
medRxiv 2022.01.13.22269211; doi: https://doi.org/10.1101/2022.01.13.22269211
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (140)
- Cardiovascular Medicine (1950)
- Dermatology (185)
- Emergency Medicine (333)
- Epidemiology (11114)
- Gastroenterology (628)
- Genetic and Genomic Medicine (3189)
- Geriatric Medicine (309)
- Health Economics (563)
- Health Informatics (2046)
- Health Policy (864)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (336)
- Neurology (2996)
- Nursing (165)
- Nutrition (465)
- Oncology (1559)
- Ophthalmology (478)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (914)
- Primary Care Research (355)
- Public and Global Health (5604)
- Radiology and Imaging (1096)
- Respiratory Medicine (763)
- Rheumatology (340)
- Sports Medicine (289)
- Surgery (346)
- Toxicology (48)
- Transplantation (159)
- Urology (133)